Talquetamab | Ajai Chari, MD | ASH 2022

Published 2022-12-20

Download video MP4 360p

Recommendations

06:31

Real-World Results from Talquetamab and Bispecific Antibodies | Carolina Schinke, MD | ASH 2023
06:02

Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma
05:39

MajesTEC-2 Trial | Emma Searle, MBChB MA MRCP FRCPath PhD | ASH 2022
10:09

Understanding Diffuse Large B-Cell Lymphoma with Jennifer Amengual, MD
17:40

What happens to lonely people under anesthesia?
$Talquetamab in Pts with Relapsed/Refractory Multiple Myeloma: Phase 1/2 Results from MonumenTAL-1$ 07:02

Talquetamab in Pts with Relapsed/Refractory Multiple Myeloma: Phase 1/2 Results from MonumenTAL-1
$Efficacy of Reduced Dosing of Talquetamab in Relapsed Refractory Myeloma | Ajai Chari, MD | ASH 2023$ 03:53

Efficacy of Reduced Dosing of Talquetamab in Relapsed Refractory Myeloma | Ajai Chari, MD | ASH 2023
03:44

What should myeloma patients know about talquetamab?
57:03

Handling Difficult Decisions and Conversations
02:41

MonumenTAL-1: talquetamab for multiple myeloma
09:29

Complicated Grief: Q & A with Dr. M. Katherine Shear
04:47

RALPH LAUREN | A Story Of Fashion And Philanthropy
17:10

Cancer types post mRNA vaccines
03:20

Suicide Prevention for Teens and Young Adults with Dr. Ali Mattu

Similar videos